Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Ottimizzazione dell'esposizione alla luce per la prevenzione e il controllo della miopia (LightSPAN) (LightSPAN)

10 novembre 2026 aggiornato da: Raymond P. Najjar, PhD, National University of Singapore

The goal of this clinical trial is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. The trial also aims to better understand the impact of light exposure on sleep and cognitive performance in children.

This trial has 3 arms namely, (1) a technical intervention arm, (2) a digital intervention arm, and (3) a control arm.

  1. technical intervention - which involves changing of classroom lighting in primary schools to ceiling lights that mimic the spectral composition of sunlight and fluctuates in intensity. Parents of children within that arm will have a sham smart-phone application (s-LightUP)
  2. digital intervention - which involves standard classroom lighting and giving parents an interventional smart-phone application (i-LightUP) that will be coupled with their child's light and activity sensor (wrist worn device ). The interventional app will provide individually tailored recommendation based on their children's behaviour (data feedback that is collected from the light and activity monitoring watch). The interventional app would then send reminder prompts/notifications to encourage parents help their children achieve required amounts of myopia-preventive light quantum target set per day.
  3. Standard care or control group which involves standard classroom lighting and parents having a sham smart-phone application (s-LightUP)

Participants will:

  • be randomised to receive either no intervention (control group), technical intervention (light intervention that mimics sunlight) or digital intervention (parents having an app that syncs with child's light and activity sensor which will provide feedback to parents to encourage and recommends increment of outdoor activities and hours).
  • have their myopia progression monitored every 6 monthly and cognitive assessment done once every 3 months over a year.
  • wear the light and activity sensor watches throughout the 1-year study period as much as possible (minimum 1 week per month) except for wet water activities such as swimming, diving and showering for research data collection purpose.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The primary objective of the study is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. To do so, we will evaluate the effectiveness, safety and feasibility of:

  1. Arm 1: technical intervention which involves spectro-temporal refinement of classroom lighting in primary schools using full spectrum light emitting diodes (LEDs) (CCT: 4000K) in addition to intermittent fluctuations in light levels. Parents of children in that arm will have access to a sham version of the LightUP mobile application to facilitate communication with the study team and questionnaire collection during the study.

  2. Arm 2: digital intervention which involves optimization of daily light exposure using an individualised behaviour-changing smart-phone application (Interventional LightUP application) coupled with child-worn light and activity sensors to provide parents with an individually tailored recommendation to adapt their children's behaviour and provide them with the required amounts of myopia-preventive light quantum/day. + standard classroom lighting

    As compared to:

  3. Arm 3: Standard care or control group which involves standard classroom lighting and no access to the interventional version of the LightUP application. Parents of children in that arm will have access to a sham version of the LightUP mobile application to facilitate communication with the study team and questionnaire collection during the study.

Our study will also lead to the following scalable and implementable outcomes:

  1. evidence-based lighting designs and policy recommendations for classrooms;
  2. a user-friendly, smart digital eyecare companion that aligns perfectly with Singapore's Smart Nation Initiative.

A secondary objective of this study is to better understand the impact of light exposure on sleep and cognitive performance in children. This will be achieved through continuous wrist actigraphy monitoring and through cognitive assessments, performed in classrooms, using tablets (one tablet/child). The assessment consists of validated, child-adapted, higher cognitive tasks testing the following constructs: impulse control, spatial working memory, content working memory, cognitive flexibility, reaction time, and processing speed.

Tipo di studio

Interventistico

Iscrizione (Stimato)

396

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

      • Singapore, Singapore, 119276
        • Reclutamento
        • National University of Singapore, Yong Loo Lin School of Medicine, Department of Ophthalmology, Eye N Brain Research Lab
        • Investigatore principale:
          • Raymond P. Najjar, PhD
        • Contatto:
      • Singapore, Singapore, 469317
        • Reclutamento
        • Bedok Green Primary School
        • Investigatore principale:
          • Raymond P Najjar, PhD
        • Contatto:
      • Singapore, Singapore, 649188
        • Reclutamento
        • Westwood Primary School
        • Investigatore principale:
          • Raymond P Najjar, PhD
        • Contatto:
      • Singapore, Singapore, 757702
        • Reclutamento
        • Wellington Primary School
        • Investigatore principale:
          • Raymond P Najjar, PhD
        • Contatto:
      • Singapore, Singapore, 297754
        • Reclutamento
        • Marymount Convent School
        • Investigatore principale:
          • Raymond P. Najjar, PhD
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 7 anni a 10 anni (Bambino)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Subject must meet all the inclusion criteria below to participate in this study.

    1. Written Informed Consent form from parent / legal guardian and assent from child subject has been obtained

    2. Is between 7 to 10 years of age at start of study intervention which is 2 January 2025 or 1 January 2026

    3. Studying in either Primary 2 or 3 classes of the participating school(s) in academic year 2025 or 2026.

    4. Presenting visual acuity or best corrected visual acuity (BCVA) better or equal to LogMAR 0.2 (equivalent to Snellen 6/9 or better) in each eye

    5. Normal Intraocular pressure (not more than 21mmHg)

    6. No ocular conditions (e.g., optic nerve disease, glaucoma, retinal diseases) except for refractive error.

    7. No ocular conditions affecting the accuracy of the ophthalmic examinations

    8. In good general health with no significant systemic diseases that may affect eye health

      Exclusion Criteria:

  • All subjects meeting any of the exclusion criteria at baseline will be excluded from participation.

    1. Previous or ongoing myopia control treatment (including but not limited to orthokeratology, atropine, pirenzepine, myopia control spectacle and contact lenses, light therapy)
    2. Ongoing participation in other myopia prevention and control research trials
    3. Any systemic or neurologic diseases (e.g. cancer, epilepsy, Kawasaki disease) known to affect eye health or make the participant vulnerable to the ophthalmic examinations (e.g., light flash)
    4. Any other conditions precluding adherence to the protocol including unwillingness to refrain from myopia control treatment for the duration of the study

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Quadruplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Technical Intervention (n=132)

Technical refinement of classroom lighting + Sham LightUP phone application (s-LightUP)

LEDs mimicking the spectrum of sunlight (4000K) administered daily for 1 academic year, every school day, for the entire school day. The light levels generated by these LEDs will fluctuate throughout the day but will remain under 1000 lux.

Sperimentale: Digital Intervention (n=132)

Standard classroom lighting + Interventional LightUP phone application (i-LightUP)

Smart-phone application (LightUP) will be synced daily to a child-worn light and activity sensor and will allow parents to track their children's outdoor time and exposure to brighter light levels across the day. The application will also nudge parents to increase their child's exposure to light (e.g., increase time outdoors, or sitting next to a window indoors) after school hours for better myopia prevention and control. i-LightUP aims to gradually assist parents in helping their children reach the ultimate goal of spending at least 2 hours per day in brighter light conditions (e.g., above 1000 lux).

Comparatore placebo: Control Group (n=132)

Standard care or control group which involves standard classroom lighting + Sham LightUP app (s-LightUP).

Standard Classroom Lighting + Sham LightUP phone application

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Cycloplegic auto-refraction
Lasso di tempo: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using autoref/kerato/pachy/tonometer

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)
Axial Length
Lasso di tempo: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using non-contact optical biometer

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)
Choroidal Thickness
Lasso di tempo: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using optical coherence tomography (OCT) scan

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Retinal and choroidal perfusion
Lasso di tempo: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using optical coherence tomography angiography (OCT-A) function within OCT machine used to measure choroidal thickness.

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)
Corneal Curvature
Lasso di tempo: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using autoref/kerato/pachy/tonometer.

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)
Corneal Thickness
Lasso di tempo: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using autoref/kerato/pachy/tonometer.

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)
Impulse control
Lasso di tempo: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

Impulse control will be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Day and Night Cards" task or a similar task will be administered on tablets (one tablet per child). Impulse control will be quantified by the number of errors committed by the children during the task which involves shifting instructions and paradigms.

1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)
Cognitive flexibility
Lasso di tempo: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

Cognitive flexibility will be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Day and Night Cards" task or a similar task will be administered on tablets (one tablet per child). Cognitive flexibility will be quantified by the number of errors committed by the children during the task which involves shifting instructions and paradigms.

1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)
Spatial working memory
Lasso di tempo: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

Spatial working memory will be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Eight Boxes" task or a similar task will be administered on tablets (one tablet per child). Spatial working memory will be quantified by the number of errors committed by the children during the task.

1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)
Content working memory
Lasso di tempo: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

Content working memory will also be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Eight Boxes" task or a similar task will be administered on tablets (one tablet per child). Content working memory will be quantified by the number of errors committed by the children during the task when remembering the content of different items in the task (e.g., strawberry, watermelon, etc.).

1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)
Processing speed
Lasso di tempo: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

Processing speed will be assessed from the previous cognitive tasks (e.g., Eight Boxes and Day and Night Cards" through the investigation of reaction time (ms) in response to the content of the tasks. The tasks will be administered on tablets (one tablet per child).

1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)
Sleep quantity
Lasso di tempo: 1 year or at least 1 week per month for 1 year

This is a secondary outcome and will depend on the days of wear of the activity and light trackers. Night time sleep quantity (minutes) will be collected through actigraphy watches given to participants.

1 year or at least 1 week per month for 1 year
Sleep efficiency
Lasso di tempo: 1 year or at least 1 week per month for 1 year

This is a secondary outcome and will depend on the days of wear of the activity and light trackers. Night time sleep efficiency (%) calculated as the amount of time spent asleep (in minutes) by the total amount of time in bed (in minutes) will be measured using actigraphy watches given to participants.

1 year or at least 1 week per month for 1 year
Height
Lasso di tempo: 1 year, at baseline and 12 months from baseline

Height of the participant in cm

1 year, at baseline and 12 months from baseline
Weight
Lasso di tempo: 1 year, at baseline and 12 months from baseline

Weight of the participant in Kg

1 year, at baseline and 12 months from baseline
Visual acuity
Lasso di tempo: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

LogMAR visual acuity test

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Daytime average light levels (lux)
Lasso di tempo: 1 year or at least 1 week per month for 1 year

Daytime average light levels (lux) collected using wearable light sensors.

1 year or at least 1 week per month for 1 year
Daytime average melanopic lux
Lasso di tempo: 1 year or at least 1 week per month for 1 year

Daytime average melanopic lux collected using wearable light sensors.

1 year or at least 1 week per month for 1 year
Time spent outdoors (questionnaires)
Lasso di tempo: 1 year or at least 1 week per month for 1 year

Estimated time spent outdoors collected using questionnaires

1 year or at least 1 week per month for 1 year
Time spent outdoors (wearables)
Lasso di tempo: 1 year or at least 1 week per month for 1 year

Calculated time spent outdoors collected using the wearable light sensors.

1 year or at least 1 week per month for 1 year
Color vision
Lasso di tempo: Baseline

Color vision assessment using the Ishihara color vision test

Baseline
Cover test (distance and near)
Lasso di tempo: 1 year, repeated every 6 months

Cover test to screen for strabismus

1 year, repeated every 6 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Raymond P. Najjar, PhD, National University of Singapore

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

21 ottobre 2024

Completamento primario (Stimato)

26 gennaio 2027

Completamento dello studio (Stimato)

26 gennaio 2027

Date di iscrizione allo studio

Primo inviato

1 ottobre 2024

Primo inviato che soddisfa i criteri di controllo qualità

5 ottobre 2024

Primo Inserito (Effettivo)

8 ottobre 2024

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

16 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • NUS-IRB-2023-767

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .